Bone marrow trephine morphology and immunohistochemical findings in chronic myelomonocytic leukaemia

British Journal of Haematology

Volumn 141, Issue 6, 2008, Pages 771-781

  Ngo, Nye Thane ^a   Lampert, Irvin A ^a   Naresh, Kikkeri N ^a  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

'myelo monocytic' nodules; Bone marrow trephine; Chronic myelomonocytic leukaemia

Indexed keywords

CD34 ANTIGEN; CD68 ANTIGEN; STEM CELL FACTOR RECEPTOR;

ADULT; AGED; ARTICLE; BONE MARROW BIOPSY; CD34 SELECTION; CHRONIC MYELOID LEUKEMIA; CHRONIC MYELOMONOCYTIC LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; FEMALE; HUMAN; HYPERPLASIA; IMMUNOHISTOCHEMISTRY; MALE; MEGAKARYOPOIESIS; POLYCYTHEMIA VERA; PRIORITY JOURNAL;

AGED; AGED, 80 AND OVER; ANTIGENS, CD34; BIOPSY; BONE MARROW CELLS; BONE MARROW EXAMINATION; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; HYPERPLASIA; LEUKEMIA, MYELOMONOCYTIC, CHRONIC; MALE; MIDDLE AGED; POLYCYTHEMIA VERA; TUMOR MARKERS, BIOLOGICAL;

EID: 44249084465     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2008.07117.x     Document Type: Article

References (29)

1. Anastasi, J. (2007) Myeloproliferative and 'overlap' Myelodysplastic/ Myeloproliferative diseases. In : Haematopathology (ed. by E.D. Hsi p. 483. Elsevier, Philadelphia, PA.
2. Bartram, C.R. (1992) Molecular genetic aspects of myelodysplastic syndromes. Hematology/oncology Clinics of North America, 6, 557 570.
3. Bennett, J.M. (2002) Chronic myelomonocytic leukemia. Current Treatment Options in Oncology, 3, 221 223.
4. Bennett, J.M., Catovsky, D., Daniel, M.T., Flandrin, G., Galton, D.A., Gralnick, H.R. Sultan, C. (1982) Proposals for the classification of the myelodysplastic syndromes. British Journal of Haematology, 51, 189 199.
5. Bennett, J.M., Catovsky, D., Daniel, M.T., Flandrin, G., Galton, D.A., Gralnick, H., Sultan, C. Cox, C. (1994) The chronic myeloid leukaemias: guidelines for distinguishing chronic granulocytic, atypical chronic myeloid, and chronic myelomonocytic leukaemia. Proposals by the French-American-British cooperative leukaemia group. British Journal of Haematology, 87, 746 754.
6. Cantu Rajnoldi, A., Fenu, S., Kerndrup, G., van Wering, E.R., Niemeyer, C.M. Baumann, I., European Working Group on Myelodysplastic Syndromes in Childhood (EWOG-MDS) 2005) Evaluation of dysplastic features in myelodysplastic syndromes: experience from the morphology group of the European working group of MDS in childhood (EWOG-MDS). Annals of Hematology, 84, 429 433.
7. Chen, Y.C., Chou, J.M., Ketterling, R.P., Letendre, L. Li, C.Y. (2003) Histologic and immunohistochemical study of bone marrow monocytic nodules in 21 cases with myelodysplasia. American Journal of Clinical Pathology, 120, 874 881.
8. Chen, Y.C., Chou, J.M., Letendre, L. Li, C.Y. (2005) Clinical importance of bone marrow monocytic nodules in patients with myelodysplasia: retrospective analysis of 21 cases. American Journal of Hematology, 79, 329 331.
9. Elliot, V., Marin, D., Horncastle, D., Elderfield, K., Apperley, J.F., Lampert, I.A. Naresh, K. (2005) Percentage of CD34 cells in a minimum 500-cell count in bone marrow trephines of patients with chronic myeloid leukaemia provides the best correlation with aspirate blast count. British Journal of Haematology, 130, 460 461.
10. Germing, U., Strupp, C., Knipp, S., Kuendgen, A., Giagounidis, A., Hildebrandt, B., Aul, C., Haas, R., Gattermann, N. Bennett, J.M. (2007) Chronic myelomonocytic leukemia in the light of the WHO proposals. Haematologica, 92, 974 977.
11. Greenberg, P., Cox, C., LeBeau, M.M., Fenaux, P., Morel, P., Sanz, G., Sanz, M., Vallespi, T., Hamblin, T., Oscier, D., Ohyashiki, K., Toyama, K., Aul, C., Mufti, G. Bennett, J. (1997) International scoring system for evaluating prognosis in myelodysplastic syndromes. Blood, 89, 2079 2088.
12. Lambertenghi-Deliliers, G., Annaloro, C., Oriani, A., Soligo, D., Pozzoli, E. Polli, E.E. (1993) Prognostic relevance of histological findings on bone marrow biopsy in myelodysplastic syndromes. Annals of Hematology, 66, 85 91.
13. Manoharan, A., Horsley, R. Pitney, W.R. (1979) The reticulin content of bone marrow in acute leukaemia in adults. British Journal of Haematology, 43, 185 190.
14. Maschek, H., Gutzmer, R., Choritz, H. Georgii, A. (1994) Life expectancy in primary myelodysplastic syndromes: a prognostic score based upon histopathology from bone marrow biopsies of 569 patients. European Journal of Haematology, 53, 280 287.
15. Maschek, H., Gutzmer, R., Choritz, H. Georgii, A. (1995) Comparison of scoring systems in primary myelodysplastic syndromes. Annals of Hematology, 70, 301 308.
16. Michaux, J.L. Martiat, P. (1993) Chronic myelomonocytic leukaemia (CMML)-a myelodysplastic or myeloproliferative syndrome? Leukemia & Lymphoma, 9, 35 41.
17. Misialek, M.J. Pechet, L. (1997) A diagnostic dilemma: chronic myelomonocytic leukemia versus atypical chronic myeloid leukemia. A case report and review of the literature. Acta Haematologica, 98, 221 227.
18. Mongkonsritragoon, W., Letendre, L., Qian, J. Li, C.Y. (1998) Nodular lesions of monocytic component in myelodysplastic syndrome. American Journal of Clinical Pathology, 110, 154 162.
19. Naresh, K.N. Lampert, I.A. (2006) CD117 expression as an aid to identify immature myeloid cells and foci of ALIP in bone marrow trephines. American Journal of Hematology, 81, 79.
20. Naresh, K.N., Lampert, I., Hasserjian, R., Lykidis, D., Elderfield, K., Horncastle, D., Smith, N., Murray-Brown, W. Stamp, G.W. (2006) Optimal processing of bone marrow trephine biopsy: the hammersmith protocol. Journal of Clinical Pathology, 59, 903 911.
21. Onida, F. Beran, M. (2004) Chronic myelomonocytic leukemia: myeloproliferative variant. Current Hematology Reports, 3, 218 226.
22. Orazi, A., Chiu, R., O'Malley, D.P., Czader, M., Allen, S.L., An, C. Vance, G.H. (2006) Chronic myelomonocytic leukemia: the role of bone marrow biopsy immunohistology. Modern Pathology: An Official Journal of the United States and Canadian Academy of Pathology, Inc, 19, 1536 1545.
23. Preisler, H., Barcos, M., Reese, P., Priore, R.L. Pothier, L. (1983) Recognition of drug resistance during remission induction therapy for acute non-lymphocytic leukemia: utility of day 6 bone marrow biopsy. Leukemia Research, 7, 67 75.
24. Rios, A., Canizo, M.C., Sanz, M.A., Vallespi, T., Sanz, G., Torrabadella, M., Gomis, F., Ruiz, C. San Miguel, J.F. (1990) Bone marrow biopsy in myelodysplastic syndromes: morphological characteristics and contribution to the study of prognostic factors. British Journal of Haematology, 75, 26 33.
25. Soligo, D., Delia, D., Oriani, A., Cattoretti, G., Orazi, A., Bertolli, V., Quirici, N. Deliliers, G.L. (1991) Identification of CD34+ cells in normal and pathological bone marrow biopsies by QBEND10 monoclonal antibody. Leukemia: Official Journal of the Leukemia Society of America, Leukemia Research Fund, U.K., 5, 1026 1030.
26. Tricot, G.J. (1992) Prognostic factors in the myelodysplastic syndromes. Leukemia Research, 16, 109 115.
27. Tricot, G., De Wolf-Peeters, C., Vlietinck, R. Verwilghen, R.L. (1984) Bone marrow histology in myelodysplastic syndromes. II. prognostic value of abnormal localization of immature precursors in MDS. British Journal of Haematology, 58, 217 225.
28. Vardiman, J.W., Pierre, R., Bain, B., Bennett, J.M., Imbert, M., Brunning, R.D. Flandrin, G. (2001) Chronic myelomonocytic leukaemia. In : World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues (ed. by E.S. Jaffe, N.L. Harris, H. Stein J.W. Vardiman p. 49. IARC press, Lyon, France.
29. Vermi, W., Facchetti, F., Rosati, S., Vergoni, F., Rossi, E., Festa, S., Remotti, D., Grigolato, P., Massarelli, G. Frizzera, G. (2004) Nodal and extranodal tumor-forming accumulation of plasmacytoid monocytes/interferon- producing cells associated with myeloid disorders. The American Journal of Surgical Pathology, 28, 585 595.